186 related articles for article (PubMed ID: 32318971)
21. The challenges of managing gout in primary care: Results of a best-practice audit.
Stamp LK; Chapman P; Hudson B; Frampton C; Hamilton G; Judd A
Aust J Gen Pract; 2019 Sep; 48(9):631-637. PubMed ID: 31476837
[TBL] [Abstract][Full Text] [Related]
22. Gout, urate-lowering therapy, and uric acid levels among adults in the United States.
Juraschek SP; Kovell LC; Miller ER; Gelber AC
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):588-92. PubMed ID: 25201123
[TBL] [Abstract][Full Text] [Related]
23. Moving urate-lowering therapy in gout beyond guideline recommendations.
Stamp LK; Dalbeth N
Semin Arthritis Rheum; 2024 Apr; 65():152358. PubMed ID: 38219395
[TBL] [Abstract][Full Text] [Related]
24. Opportunities for improving medication use and monitoring in gout.
Singh JA; Hodges JS; Asch SM
Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
[TBL] [Abstract][Full Text] [Related]
25. Management of Gout.
Anderson IJ; Davis AM; Jan RH
JAMA; 2021 Dec; 326(24):2519-2520. PubMed ID: 34962547
[No Abstract] [Full Text] [Related]
26. Prevalence of treatment of hyperuricemic in patients admitted to the rheumatology ward and evaluation of compliance with the 2012 ACR Guidelines.
Banse C; Fardellone P; Paccou J
Joint Bone Spine; 2014 Oct; 81(5):461-2. PubMed ID: 24703403
[No Abstract] [Full Text] [Related]
27. [The Dutch College of General Practitioners' "Gout" Standard: a response from rheumatologists].
Jacobs JW; Bijlsma JW
Ned Tijdschr Geneeskd; 2002 Feb; 146(7):295-6. PubMed ID: 11876030
[TBL] [Abstract][Full Text] [Related]
28. What Is the Evidence for Treat-to-Target Serum Urate in Gout?
Bursill D; Dalbeth N
Curr Rheumatol Rep; 2018 Mar; 20(3):11. PubMed ID: 29516287
[TBL] [Abstract][Full Text] [Related]
29. A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout.
Phang KF; Santosa A; Low BPL; Tan PSH; Khong ZW; Lim AYN; Teng GG; Tay SH
Int J Rheum Dis; 2020 Aug; 23(9):1136-1144. PubMed ID: 32483906
[TBL] [Abstract][Full Text] [Related]
30. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.
Keenan RT
Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200
[TBL] [Abstract][Full Text] [Related]
31. Management of gout in the real world: current practice versus guideline recommendations.
Doghramji PP; Fermer S; Wood R; Morlock R; Baumgartner S
Postgrad Med; 2016 Jan; 128(1):106-14. PubMed ID: 26592538
[TBL] [Abstract][Full Text] [Related]
32. Development of the American College of Rheumatology Electronic Clinical Quality Measures for Gout.
FitzGerald JD; Mikuls TR; Neogi T; Singh JA; Robbins M; Khanna PP; Turner AS; Myslinski R; Suter LG
Arthritis Care Res (Hoboken); 2018 May; 70(5):659-671. PubMed ID: 29649348
[TBL] [Abstract][Full Text] [Related]
33. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.
Cottrell E; Crabtree V; Edwards JJ; Roddy E
BMC Fam Pract; 2013 Nov; 14():170. PubMed ID: 24225170
[TBL] [Abstract][Full Text] [Related]
34. Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.
Soskind R; Abazia DT; Bridgeman MB
Expert Opin Pharmacother; 2017 Aug; 18(11):1115-1125. PubMed ID: 28658988
[TBL] [Abstract][Full Text] [Related]
35. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.
Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
JAMA; 2014 Dec 24-31; 312(24):2684-6. PubMed ID: 25536262
[No Abstract] [Full Text] [Related]
36. Chronic gout: Barriers to effective management.
Rogenmoser S; Arnold MH
Aust J Gen Pract; 2018 Jun; 47(6):351-356. PubMed ID: 29966174
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review.
Sivera F; Andrès M; Falzon L; van der Heijde DM; Carmona L
J Rheumatol Suppl; 2014 Sep; 92():3-8. PubMed ID: 25180122
[TBL] [Abstract][Full Text] [Related]
38. An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study.
Perez-Ruiz F; Carmona L; Yébenes MJ; Pascual E; de Miguel E; Ureña I; González-Gay MA;
J Clin Rheumatol; 2011 Oct; 17(7):349-55. PubMed ID: 21946457
[TBL] [Abstract][Full Text] [Related]
39. Crystal arthritis: a new 'package of care' strategy for effective gout management.
Dalbeth N
Nat Rev Rheumatol; 2012 Sep; 8(9):507-8. PubMed ID: 22847469
[No Abstract] [Full Text] [Related]
40. The Hong Kong Society of Rheumatology consensus recommendations for the management of gout.
Yip RM; Cheung TT; So H; Chan JP; Ho CT; Tsang HH; Yu CK; Wong PC;
Clin Rheumatol; 2023 Aug; 42(8):2013-2027. PubMed ID: 37014501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
